Suchergebnisse - RERO DOC

Consortium of Swiss Academic Libraries

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Borner, M. ; Koeberle, D. ; Von Moos, R. ; Saletti, P. ; Rauch, D. ; Hess, V. ; Trojan, A. ; Helbling, D. ; Pestalozzi, B. ; Caspar, C. ; Ruhstaller, T. ; Roth, A. ; Kappeler, A. ; Dietrich, D. ; Lanz, D. ; Mingrone, W.

In: Annals of Oncology, 2008, vol. 19, no. 7, p. 1288-1292

Consortium of Swiss Academic Libraries

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Ruhstaller, T. ; Widmer, L. ; Schuller, J. C. ; Roth, A. ; Hess, V. ; Mingrone, W. ; von Moos, R. ; Borner, M. ; Pestalozzi, B. C. ; BalmerMajno, S. ; Köberle, D. ; Terraciano, L. ; Schnider, A. ; Bodis, S. ; Popescu, R.

In: Annals of Oncology, 2009, vol. 20, no. 9, p. 1522-1528

Consortium of Swiss Academic Libraries

Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study

Seium, Y. ; Stupp, R. ; Ruhstaller, T. ; Gervaz, P. ; Mentha, G. ; Philippe, M. ; Allal, A. ; Trembleau, C. ; Bauer, J. ; Morant, R. ; Roth, A. D.

In: Annals of Oncology, 2005, vol. 16, no. 5, p. 762-766

Consortium of Swiss Academic Libraries

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Rochlitz, C. ; Ruhstaller, T. ; Lerch, S. ; Spirig, C. ; Huober, J. ; Suter, T. ; Bühlmann, M. ; Fehr, M. ; Schönenberger, A. ; von Moos, R. ; Winterhalder, R. ; Rauch, D. ; Müller, A. ; Mannhart-Harms, M. ; Herrmann, R. ; Cliffe, B. ; Mayer, M. ; Zaman, K.

In: Annals of Oncology, 2011, vol. 22, no. 1, p. 80-85

Powered by Invenio
/ © Copyright RERO